Thomas Malley - Insider Trading & Ownership

Entity
Individual
Location
C/O Kiniksa Pharmaceuticals, Ltd., Clarendon House, 2 Church Street, Hamilton, Bermuda
Summary
The estimated net worth of Thomas Malley is at least $16.7M dollars as of June 7, 2024. Thomas Malley is the Director of BeiGene, Ltd. and owns shares of BeiGene, Ltd. (BGNE) stock worth about $15.1M. Thomas Malley is the Director of Kura Oncology, Inc. and owns shares of Kura Oncology, Inc. (KURA) stock worth about $1.6M.
All Insider Reports
All Insider Reports

Ownership of Thomas Malley

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BGNE, BEIGF BeiGene, Ltd. Director $15.1M Jun 15, 2023
KURA Kura Oncology, Inc. Director $1.6M Jun 5, 2024
KNSA Kiniksa Pharmaceuticals International, plc Director Jun 5, 2024

Insider Transactions Reported by Thomas Malley:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.